Clinical Trial Update: Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study [Phase 2, Phase 3]

View source ↗

Summary

A non-comparative extension trial assesses safety and efficacy of deferasirox in transfusion-dependent iron overload with liver involvement; results from a Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Liver Iron Overload
• Transfusion-dependent Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Liver Iron Overload | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2011-08-11